| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |